DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Medivation, Inc. (NASDAQ: MDVN)

132.00 3.62 (2.82%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MDVN $132.00 2.82%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $131.08
Previous Close $128.38
Daily Range $128.63 - $133.80
52-Week Range $54.37 - $141.58
Market Cap $10.3B
P/E Ratio 37.54
Dividend (Yield) $0.00 (0.0%)
Volume 738,204
Average Daily Volume 1,042,851
Current FY EPS $3.10

Sector

Healthcare

Industry

Drug Makers

Medivation, Inc. (MDVN) Description

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies. Website: http://www.medivation.net/

News & Commentary Rss Feed

Best One-Drug Wonder Stock for 2015

You've got to start somewhere. Here's our top picks of biotechs with just one drug on the market.

Medivation-Astellas' Xtandi Positive in Prostate Cancer Study - Analyst Blog

3 Biotech Stocks Bucking Short Interest Trends

Brean Capital Reiterates Buy Rating, Raises PT On Medivation As Xtandi Deserves To Move Upstream

Jeff Cooper: Biotech and the Dollar Blink

The reversals in biotech and the US dollar are worth watching.

Trade-Ideas: Medivation (MDVN) Is Today's New Lifetime High Stock

Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press

Zacks Industry Outlook Highlights: Orexigen, MannKind, Amgen, Medivation and Express Scripts - Press Releases

Medigene AG: Addressing The CAR-T Market Pain Points

Wedbush Securities Reiterates Outperform, Raises PT On Medivation On Increased International Estimat

Wedbush Securities Reiterates Outperform, Raises PT On Medivation On Increased International Estimates

Johnson & Johnson Might Have The Last Laugh Over AbbVie Winning Pharmacyclics

See More MDVN News...

MDVN's Top Competitors

MDVN $132.00 (2.82%)
Current stock: MDVN
ILMN $187.17 (1.52%)
Current stock: ILMN
TMO $133.69 (0.47%)
Current stock: TMO
WAT $124.11 (1.85%)
Current stock: WAT